Synchronous inflammatory breast cancer and advanced ovarian carcinoma: A case with prolonged disease-free survival

Despite the known association of these malignancies, the incidence of a synchronous presentation of breast and ovarian cancer is low, and the current literature does not address an approach to this clinical problem directly. We report a greater than 2.5 year disease-free survival in a patient treate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 1999-05, Vol.10 (5), p.585-588
Hauptverfasser:	Sandor, V., Reed, E., Sarosy, G., Middleton, L. P., Davis, P., Kohn, E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - pathology Chemotherapy cisplatin Female Humans Medical sciences Middle Aged Neoplasms, Multiple Primary - drug therapy Neoplasms, Multiple Primary - pathology ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology paclitaxel Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Despite the known association of these malignancies, the incidence of a synchronous presentation of breast and ovarian cancer is low, and the current literature does not address an approach to this clinical problem directly. We report a greater than 2.5 year disease-free survival in a patient treated for synchronous stage IIIB inflammatory breast cancer and stage IIIC epithelial ovarian cancer. The prolonged disease-free survival in our case may provide some guidance in this unusual clinical situation.
ISSN:	0923-7534 1569-8041
DOI:	10.1023/A:1008239124657